WallStreetZenWallStreetZen

NASDAQ: BMRA
Biomerica Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

BMRA past revenue growth

How has BMRA's revenue growth performed historically?
Company
-43.29%
Industry
9.4%
Market
17.57%
BMRA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BMRA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BMRA's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BMRA earnings and revenue history

Current Revenue
$5.4M
Current Earnings
-$6.3M
Current Profit Margin
-117.5%

BMRA Return on Equity

Current Company
-64%
Current Industry
9.5%
Current Market
28.2%
BMRA's Return on Equity (-64%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BMRA announces earnings.

BMRA Return on Assets

Current Company
-51%
Current Industry
4.9%
BMRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BMRA Return on Capital Employed

Current Company
-75.45%
Current Industry
8%
BMRA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BMRA vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BMRA$5.41M-$5.94M-$6.35M+0.91%N/A
DHAI$0.00$1.46M$1.46MN/AN/A
BTCY$11.63M-$9.92M-$15.39M+121.10%N/A
TBIO$27.51M-$40.49M-$49.02M+54.68%N/A
NXL$110.75k-$4.60M-$4.65M-81.64%N/A
View Top Medical Device Stocks

Biomerica Earnings & Revenue FAQ

What were BMRA's earnings last quarter?

On Invalid Date, Biomerica (NASDAQ: BMRA) reported Q1 2024 earnings per share (EPS) of -$0.11, up 8.33% year over year. Total Biomerica earnings for the quarter were -$1.92 million. In the same quarter last year, Biomerica's earnings per share (EPS) was -$0.12.

If you're new to stock investing, here's how to buy Biomerica stock.

What was BMRA's earnings growth in the past year?

As of Q2 2024, Biomerica's earnings has grown year over year. Biomerica's earnings in the past year totalled -$6.35 million.

What was BMRA's revenue last quarter?

On Invalid Date, Biomerica (NASDAQ: BMRA) reported Q1 2024 revenue of $1.02 million up 8.46% year over year. In the same quarter last year, Biomerica's revenue was $1.11 million.

What was BMRA's revenue growth in the past year?

As of Q2 2024, Biomerica's revenue has grown -43.29% year over year. This is 52.69 percentage points lower than the US Medical Devices industry revenue growth rate of 9.4%. Biomerica's revenue in the past year totalled $5.41 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.